30 november, 2023 Regulatoriskt AcuCort publishes the Interim Report for the third quarter 2023 (in Swedish)
31 augusti, 2023 Regulatoriskt AcuCort signs partnership agreement for the four major Nordic countries with Unimedic Pharma
28 april, 2023 Regulatoriskt AcuCort publishes the Interim Report for the first quarter 2023 (in Swedish)
20 februari, 2023 Regulatoriskt The FDA is requesting additional information prior to AcuCort's registration application in the United States
24 januari, 2023 Regulatoriskt AcuCort receives market approval from the Finnish Medicines Agency for the drug Zeqmelit®